C07D 201/10

Technology



back to "C07D 201/10" profile

More Results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9624242 11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate saltFeb 13, 15Apr 18, 17CTI BioPharma Corp.
8980873 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate saltDec 09, 09Mar 17, 15CTI BioPharma Corp.
5610176 Tachykinin (NK1) receptor antagonistsSep 07, 95Mar 11, 97Warner-Lambert Company
4647661 Method of preparing .omega.-lactams, in particular caprolactamMar 27, 86Mar 03, 87Chimica del Friuli S.p.A., CHIMICA DEL FRUILI S.P.A. PIAZZALE F. MARINOTTI,
4349473 Process for the preparation of .omega.-lactams, in particular caprolactamOct 21, 80Sep 14, 82Snia Viscosa Societa' Nazionale Industria Applicazioni Viscosa SpA